Literature DB >> 2774058

Formalin-resistant leukocyte surface antigens in the diagnosis of cutaneous malignant lymphomas.

A Hauschild1, W Sterry.   

Abstract

Immunophenotyping of routinely embedded lymphoma biopsies, increasingly used in nodal lymphomas, has not been systematically performed in cutaneous lymphomas. Eight monoclonal antibodies were tested directed against formalin resistant antigens (T cell biased: UCHL1, MT1; B cell biased: 4KB5, L26, Ki-B3; HLA-class II: CBL 120; activation antigens: Ber-H2; myeloid biased: Mac 387, M1) in cutaneous T (N = 29) and B (N = 10) cell lymphomas and pseudolymphomas (N = 9). UCHL1 and MT1 showed a high specificity and sensitivity. B cell-restricted antibodies L26 and 4KB5 showed the best sensitivity and specificity among the B cell-associated antibodies; Ki-B3 showed aberrant expression on T cells in some cases. Ber-H2 (CD30) was demonstrated in most cases of large cell anaplastic lymphoma and single cases of other lymphomas and lymphomatoid papulosis. Class II antigen expression, as determined by CBL 120, showed good specificity but low sensitivity, and antibodies directed against myeloid antigens did not react with tumor cells.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2774058      PMCID: PMC1880237     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  19 in total

1.  Functional subsets of human helper-inducer cells defined by a new monoclonal antibody, UCHL1.

Authors:  S H Smith; M H Brown; D Rowe; R E Callard; P C Beverley
Journal:  Immunology       Date:  1986-05       Impact factor: 7.397

2.  Leu-M1--a marker for Reed-Sternberg cells in Hodgkin's disease. An immunoperoxidase study of paraffin-embedded tissues.

Authors:  G S Pinkus; P Thomas; J W Said
Journal:  Am J Pathol       Date:  1985-05       Impact factor: 4.307

3.  A new working formulation of non-Hodgkin's lymphomas. A retrospective study of the new NCI classification proposal in comparison to the Rappaport and Kiel classifications.

Authors:  G R Krueger; J R Medina; H O Klein; A Konrads; J Zach; M Rister; G Janik; K G Evers; T Hirano; H Kitamura; V A Bedoya
Journal:  Cancer       Date:  1983-09-01       Impact factor: 6.860

4.  Detailed phenotypic analysis of B-cell lymphoma using a panel of antibodies reactive in routinely fixed wax-embedded tissue.

Authors:  A J Norton; P G Isaacson
Journal:  Am J Pathol       Date:  1987-08       Impact factor: 4.307

5.  Use of the monoclonal antibody WR17, identifying the CD37 gp40-45 Kd antigen complex, in the diagnosis of B-lymphoid malignancy.

Authors:  K Moore; S A Cooper; D B Jones
Journal:  J Pathol       Date:  1987-05       Impact factor: 7.996

6.  Monoclonal antibody Ki-B3 detects a formalin resistant antigen on normal and neoplastic B cells.

Authors:  A C Feller; H H Wacker; G Moldenhauer; H J Radzun; M R Parwaresch
Journal:  Blood       Date:  1987-09       Impact factor: 22.113

7.  An immunocytochemical study of T-cell lymphomas using monoclonal and polyclonal antibodies effective in routinely fixed wax embedded tissues.

Authors:  A J Norton; P G Isaacson
Journal:  Histopathology       Date:  1986-12       Impact factor: 5.087

8.  Monoclonal antibodies marking T lymphocytes in paraffin-embedded tissue.

Authors:  J Linder; Y L Ye; D S Harrington; J O Armitage; D D Weisenburger
Journal:  Am J Pathol       Date:  1987-04       Impact factor: 4.307

9.  An evaluation of the utility of anti-granulocyte and anti-leukocyte monoclonal antibodies in the diagnosis of Hodgkin's disease.

Authors:  R F Dorfman; K C Gatter; K A Pulford; D Y Mason
Journal:  Am J Pathol       Date:  1986-06       Impact factor: 4.307

10.  Identification of Hodgkin and Sternberg-reed cells as a unique cell type derived from a newly-detected small-cell population.

Authors:  H Stein; J Gerdes; U Schwab; H Lemke; D Y Mason; A Ziegler; W Schienle; V Diehl
Journal:  Int J Cancer       Date:  1982-10-15       Impact factor: 7.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.